Does CANAGLIFLOZIN Cause Diabetic nephropathy? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Diabetic nephropathy have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 0.0% of all adverse event reports for CANAGLIFLOZIN.
9
Reports of Diabetic nephropathy with CANAGLIFLOZIN
0.0%
of all CANAGLIFLOZIN reports
1
Deaths
3
Hospitalizations
How Dangerous Is Diabetic nephropathy From CANAGLIFLOZIN?
Of the 9 reports, 1 (11.1%) resulted in death, 3 (33.3%) required hospitalization.
Is Diabetic nephropathy Listed in the Official Label?
Yes, Diabetic nephropathy is listed as a known adverse reaction in the official FDA drug label for CANAGLIFLOZIN.
What Other Side Effects Does CANAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,413)
Toe amputation (2,193)
Osteomyelitis (2,146)
Acute kidney injury (1,853)
Fungal infection (1,385)
Gangrene (1,081)
Weight decreased (1,014)
Cellulitis (1,007)
Urinary tract infection (920)
Diabetic foot infection (832)
What Other Drugs Cause Diabetic nephropathy?
LANSOPRAZOLE (625)
OMEPRAZOLE (496)
ESOMEPRAZOLE (394)
PANTOPRAZOLE (360)
METFORMIN (83)
INSULIN GLARGINE (64)
DEXLANSOPRAZOLE (51)
TACROLIMUS (47)
INSULIN ASPART (37)
INSULIN LISPRO (36)
Which CANAGLIFLOZIN Alternatives Have Lower Diabetic nephropathy Risk?
CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN
CANAGLIFLOZIN vs CANAKINUMAB
CANAGLIFLOZIN vs CANDESARTAN
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE